BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12942160)

  • 1. Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier.
    Ningaraj NS; Rao M; Black KL
    Drug News Perspect; 2003 Jun; 16(5):291-8. PubMed ID: 12942160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.
    Ningaraj NS; Rao M; Hashizume K; Asotra K; Black KL
    J Pharmacol Exp Ther; 2002 Jun; 301(3):838-51. PubMed ID: 12023511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
    Ningaraj NS; Rao MK; Black KL
    Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
    Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
    Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
    Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
    Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
    Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
    Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
    Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
    J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone enhances calcium-activated potassium channel expression in blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Xue YX; Wang P; Zhang H; Qin LJ; Liu LB
    Brain Res; 2009 Mar; 1259():1-6. PubMed ID: 19401176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
    Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
    Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
    Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
    Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
    Gu YT; Xue YX; Wei XY; Zhang H; Li Y
    Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
    Zhang H; Gu YT; Xue YX
    Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.
    Black KL; Yin D; Ong JM; Hu J; Konda BM; Wang X; Ko MK; Bayan JA; Sacapano MR; Espinoza A; Irvin DK; Shu Y
    Brain Res; 2008 Sep; 1230():290-302. PubMed ID: 18674521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Zhang H; Xue YX
    Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
    Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
    Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.